Of the 18 patients who did not receive HAART with primary ITP therapy, 12 had a CD4 count >200  cells/μL and 13 had IDU as their risk factor for HIV, including the six patients with a CD4 count <200  cells/μL. Here, CD4 is linked to autoimmune thrombocytopenic purpura.